Return to search results.
Complete title: A Phase III Double-blinded, Placebo Controlled Study of XilonixTM for Improving Survival in Metastatic Colorectal Cancer
|Research Study Number||8041|
|Principal Investigator||Andrew Coveler, MD|
Research Study Description
Eligibility Criteria (must meet the following to participate in this study)
Other eligibility criteria may apply.
Colon Cancer; Gastrointestinal Cancer; Solid Tumors; Digestive System Neoplasms; Colorectal Neoplasms
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.